Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Baricitinib for refractory chronic graft-versus-host disease: results of a phase 1/2 study.
Journal: Blood advances
Published: October 27, 2025
Baricitinib for refractory chronic graft-versus-host-disease: Results of a phase 1/2 study.
Journal: Blood advances
Published: October 27, 2025
Efficacy of Pomalidomide on Motor Performance and Functional Abilities in Patients with Steroid Refractory Chronic Graft Versus Host Disease: A Randomized Clinical Study.
Journal: Transplantation and cellular therapy
Published: April 01, 2024
High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention.
Journal: Blood advances
Published: June 15, 2023
Collection of peripheral blood mononucleated cells for chronic graft-versus-host disease immunology research: safety and effectiveness of leukapheresis in 132 patients.
Journal: Journal of translational medicine
Published: August 21, 2022
Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host disease.
Journal: Bone marrow transplantation
Published: September 18, 2020
Clinical characteristics and cytokine biomarkers in patients with chronic graft-vs-host disease persisting seven or more years after diagnosis.
Journal: American journal of hematology
Published: September 24, 2019
Achalasia in a Patient Undergoing Hematologic Stem Cell Transplant After Exposure to Tacrolimus.
Journal: Mayo Clinic proceedings. Innovations, quality & outcomes
Published: September 19, 2018
Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patients.
Journal: Bone marrow transplantation
Published: March 08, 2018
Last Updated: 09/26/2026